VennHealth® is a stand-alone, easy-to-use Excel-based program that allows you to quickly and reliably query comorbidity data for the U.S. market. With access to comprehensive and reliable data, you're able to gain better knowledge of your product's market to:

  • Establish the value of additional and possibly related indications
  • Understand the magnitude of patients that may be excluded from therapy
  • Create custom patient segmentation in comorbid diseases/conditions
  • Determine diagnosis rates in the general population

How can VennHealth® help you?

By analyzing comorbidity data using VennHealth®, you're able to:

  • Eliminate errors – Avoid "double-counting" potential patients in your forecast for products that can be used to treat more than one disease or condition.
  • Facilitate better drug development planning – A pharmaceutical product with a broad range of efficacy may have a marketing advantage in therapeutic areas with a high level of disease/condition comorbidity.
  • Create more useful forecasts – Provide an accurate forecast of market potential in both exclusive and overlapping segments among a variety of conditions or diseases. Based on the most recent data, results are projected to future years for easy import into a forecasting model.

VennHealth® consists of two modules: General Health and CNS.

General Health module:

Data is sourced from the National Health and Nutrition Examination Survey.

31 definable conditions in 8 main categories:

  • Cardiology
  • Infectious Disease
  • Oncology
  • Respiratory
  • Sleep Disorders
  • Urology
  • Other Diseases
  • Other Measures

Flexible disease definition through:

  • Diagnostic threshold limits
  • Inclusion or exclusion of diagnosed and/or treated patients
CNS module:

Data is sourced from the National Comorbidity Survey Replication.

Covers 23 conditions in 5 main categories, including:

  • Anxiety Disorders
  • Mood Disorders
  • Impulse Disorder
  • Substance Use Disorders
  • Eating Disorders

Flexible disease definition through:

  • ICD-10-CM or DSM-IV diagnostic criteria
  • Timeframe of diagnosis (30 day, 12 month)